Quadria Capital invests Rs 850 cr in NephroPlus

Hyderabad: Quadria Capital, a healthcare-focused private equity firms, has announced an investment of Rs 850 crore in NephroPlus, Asia’s largest dialysis network. Through this transaction, Quadria will acquire a significant minority stake through a combination of a primary investment and the purchase of shares from existing shareholders. The transaction will support NephroPlus in serving the growing demand for high quality, affordable dialysis services across India and other markets in Asia.

NephroPlus is a uniquely positioned dialysis provider operating in sizeable, high-growth markets across Asia with dominant leadership in India and a fast-growing footprint in the Philippines and other Asian countries. The company serves patients across dialysis centres in marquee hospitals and at standalone clinics, working with leading nephrologists. NephroPlus also delivers care through public-private partnerships in both urban and rural areas.

Demand for dialysis services in the company’s target markets is expected to grow at a rate of over 11 per cent annually over the next five years. The company has a successful track record of growing via bolt-on acquisitions and plans to do more acquisitions in the future. With Quadria’s support, NephroPlus aims to leverage its strong brand, operational expertise, trusted relationships with leading nephrologists, to capitalise on growth opportunities and expand its market leadership, a company release states.

Vikram Vuppala, Founder and CEO of NephroPlus, said: “Our business has evolved tremendously over the past few years and today we are proud to be one of the fastest growing and most trusted providers of high-quality dialysis to around 30,000 patients. We look forward to expanding in India, our core market, while exploring further opportunities to bring our expertise and clinical excellence to more patients in other global markets. Quadria’s healthcare expertise, capital and focus on operational value creation will put us in an even better position to keep scaling, innovating, and delivering affordable and high-quality care.”

Sunil Thakur, Partner and Head of South Asia at Quadria Capital, said: “Quadria’s investment in NephroPlus underscores our ambition to invest in regional champions of Asian healthcare, who are providing high-quality, affordable healthcare to large, under-served populations. Our partner has demonstrated its ability to significantly improve health outcomes for its patients, while maintaining industry-leading growth and profitability. We look forward to working with their leadership team to continue to expand their footprint, increase access to dialysis services across Asia and accelerate the next phase of growth for them.”